Protalix Biotherapeutics, Inc. (PLX)
1.74
-0.05
(-2.79%)
USD |
NYAM |
Dec 15, 16:00
1.755
+0.02
(+0.86%)
Pre-Market: 20:00
Protalix Biotherapeutics Gross Profit (Annual): 29.08M for Dec. 31, 2024
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Agenus, Inc. | 89.63M |
| Curis, Inc. | 10.61M |
| Halozyme Therapeutics, Inc. | 784.86M |
| AIM ImmunoTech, Inc. | -0.107M |
| Armata Pharmaceuticals, Inc. | 3.849M |